PCN22 FIRST-LINE TREATMENT AND LIFETIME MEDICAL-CARE COSTS AMONG ELDERLY STAGE IIIB/IV NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH COMMONLY USED DOUBLET THERAPIES
May 1, 2007, 00:00
10.1016/S1098-3015(10)68933-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)68933-4/fulltext
Title :
PCN22 FIRST-LINE TREATMENT AND LIFETIME MEDICAL-CARE COSTS AMONG ELDERLY STAGE IIIB/IV NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH COMMONLY USED DOUBLET THERAPIES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68933-4&doi=10.1016/S1098-3015(10)68933-4
First page :
Section Title :
Open access? :
No
Section Order :
116